BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 16603536)

  • 1. Chimeric peptide vaccine composed of B- and T-cell epitopes of human T-cell leukemia virus type 1 induces humoral and cellular immune responses and reduces the proviral load in immunized squirrel monkeys (Saimiri sciureus).
    Kazanji M; Heraud JM; Merien F; Pique C; de Thé G; Gessain A; Jacobson S
    J Gen Virol; 2006 May; 87(Pt 5):1331-1337. PubMed ID: 16603536
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lymphoid organs as a major reservoir for human T-cell leukemia virus type 1 in experimentally infected squirrel monkeys (Saimiri sciureus): provirus expression, persistence, and humoral and cellular immune responses.
    Kazanji M; Ureta-Vidal A; Ozden S; Tangy F; de Thoisy B; Fiette L; Talarmin A; Gessain A; de Thé G
    J Virol; 2000 May; 74(10):4860-7. PubMed ID: 10775625
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epitope-based universal vaccine for Human T-lymphotropic virus-1 (HTLV-1).
    Raza MT; Mizan S; Yasmin F; Akash AS; Shahik SM
    PLoS One; 2021; 16(4):e0248001. PubMed ID: 33798232
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunogenicity and protective efficacy of recombinant human T-cell leukemia/lymphoma virus type 1 NYVAC and naked DNA vaccine candidates in squirrel monkeys (Saimiri sciureus).
    Kazanji M; Tartaglia J; Franchini G; de Thoisy B; Talarmin A; Contamin H; Gessain A; de Thé G
    J Virol; 2001 Jul; 75(13):5939-48. PubMed ID: 11390595
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human T-cell leukemia virus type-I (HTLV-I)-specific T-cell responses detected using three-divided glutathione-S-transferase (GST)-Tax fusion proteins.
    Kurihara K; Shimizu Y; Takamori A; Harashima N; Noji M; Masuda T; Utsunomiya A; Okamura J; Kannagi M
    J Immunol Methods; 2006 Jun; 313(1-2):61-73. PubMed ID: 16723135
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A peptide-based human T cell leukemia virus type I vaccine containing T and B cell epitopes that induces high titers of neutralizing antibodies.
    Baba E; Nakamura M; Ohkuma K; Kira J; Tanaka Y; Nakano S; Niho Y
    J Immunol; 1995 Jan; 154(1):399-412. PubMed ID: 7527817
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human T cell lymphotropic virus type I (HTLV-I)-specific CD4+ T cells: immunodominance hierarchy and preferential infection with HTLV-I.
    Goon PK; Igakura T; Hanon E; Mosley AJ; Barfield A; Barnard AL; Kaftantzi L; Tanaka Y; Taylor GP; Weber JN; Bangham CR
    J Immunol; 2004 Feb; 172(3):1735-43. PubMed ID: 14734756
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunological changes and cytokine gene expression during primary infection with human T-cell leukaemia virus type 1 in squirrel monkeys (Saimiri sciureus).
    Heraud JM; Merien F; Mortreux F; Mahieux R; Kazanji M
    Virology; 2007 May; 361(2):402-11. PubMed ID: 17223152
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protective efficacy of multiepitope human leukocyte antigen-A*0201 restricted cytotoxic T-lymphocyte peptide construct against challenge with human T-cell lymphotropic virus type 1 Tax recombinant vaccinia virus.
    Sundaram R; Lynch MP; Rawale S; Dakappagari N; Young D; Walker CM; Lemonnier F; Jacobson S; Kaumaya PT
    J Acquir Immune Defic Syndr; 2004 Nov; 37(3):1329-39. PubMed ID: 15483462
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term persistence of protective immunity in cynomolgus monkeys immunized with a recombinant vaccinia virus expressing the human T cell leukaemia virus type I envelope gene.
    Ibuki K; Funahashi SI; Yamamoto H; Nakamura M; Igarashi T; Miura T; Ido E; Hayami M; Shida H
    J Gen Virol; 1997 Jan; 78 ( Pt 1)():147-52. PubMed ID: 9010298
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro peptide immunization of target tax protein human T-cell leukemia virus type 1-specific CD4+ helper T lymphocytes.
    Kobayashi H; Ngato T; Sato K; Aoki N; Kimura S; Tanaka Y; Aizawa H; Tateno M; Celis E
    Clin Cancer Res; 2006 Jun; 12(12):3814-22. PubMed ID: 16778109
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The humoral immune response to human T-cell lymphotropic virus type 1 envelope glycoprotein gp46 is directed primarily against conformational epitopes.
    Hadlock KG; Rowe J; Foung SK
    J Virol; 1999 Feb; 73(2):1205-12. PubMed ID: 9882322
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HTLV-I infection in squirrel monkeys (Saïmiri sciureus) using autologous, homologous, or heterologous HTLV-I-transformed cell lines.
    Kazanji M; Moreau JP; Mahieux R; Bonnemains B; Bomford R; Gessain A; de Thé G
    Virology; 1997 May; 231(2):258-66. PubMed ID: 9168888
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HTLV type 1 infection in squirrel monkeys (Saimiri sciureus): a promising animal model for HTLV type 1 human infection.
    Kazanji M
    AIDS Res Hum Retroviruses; 2000 Nov; 16(16):1741-6. PubMed ID: 11080820
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of a cytotoxic T-cell assay in rabbits to evaluate early immune response to human T-lymphotropic virus type 1 infection.
    Haynes RA; Phipps AJ; Yamamoto B; Green P; Lairmore MD
    Viral Immunol; 2009 Dec; 22(6):397-405. PubMed ID: 19951176
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Among all human T-cell leukemia virus type 1 proteins, tax, polymerase, and envelope proteins are predicted as preferential targets for the HLA-A2-restricted cytotoxic T-cell response.
    Pique C; Connan F; Levilain JP; Choppin J; Dokhélar MC
    J Virol; 1996 Aug; 70(8):4919-26. PubMed ID: 8763995
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Target epitope in the Tax protein of human T-cell leukemia virus type I recognized by class I major histocompatibility complex-restricted cytotoxic T cells.
    Kannagi M; Shida H; Igarashi H; Kuruma K; Murai H; Aono Y; Maruyama I; Osame M; Hattori T; Inoko H
    J Virol; 1992 May; 66(5):2928-33. PubMed ID: 1373197
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased expression of human T lymphocyte virus type I (HTLV-I) Tax11-19 peptide-human histocompatibility leukocyte antigen A*201 complexes on CD4+ CD25+ T Cells detected by peptide-specific, major histocompatibility complex-restricted antibodies in patients with HTLV-I-associated neurologic disease.
    Yamano Y; Cohen CJ; Takenouchi N; Yao K; Tomaru U; Li HC; Reiter Y; Jacobson S
    J Exp Med; 2004 May; 199(10):1367-77. PubMed ID: 15136590
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reduced frequency, diversity, and function of human T cell leukemia virus type 1-specific CD8+ T cell in adult T cell leukemia patients.
    Kozako T; Arima N; Toji S; Masamoto I; Akimoto M; Hamada H; Che XF; Fujiwara H; Matsushita K; Tokunaga M; Haraguchi K; Uozumi K; Suzuki S; Takezaki T; Sonoda S
    J Immunol; 2006 Oct; 177(8):5718-26. PubMed ID: 17015761
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A replication competent adenovirus 5 host range mutant-simian immunodeficiency virus (SIV) recombinant priming/subunit protein boosting vaccine regimen induces broad, persistent SIV-specific cellular immunity to dominant and subdominant epitopes in Mamu-A*01 rhesus macaques.
    Malkevitch N; Patterson LJ; Aldrich K; Richardson E; Alvord WG; Robert-Guroff M
    J Immunol; 2003 Apr; 170(8):4281-9. PubMed ID: 12682263
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.